Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00127413 · ClinicalTrials.gov registry record · NA
Integrated Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT00127413: Completed NA study, sponsored by US Department of Veterans Affairs.
NCT00127413 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 42 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00127413, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the efficacy of an integrated treatment for Veterans with comorbid chronic pain and posttraumatic stress disorder (PTSD). It is hypothesized that Veterans who receive the integrated treatment will report more positive outcomes than individuals who are assigned to treatment as usual, pain treatment, or PTSD treatment.
Primary Outcome
This 30-item structured interview is designed to assess both the 17 symptoms of PTSD and the 8 hypothesized associated features. The scale yields a dichotomous diagnosis of PTSD, and also provides a continuous score of frequency and severity for each symptom. In addition, a behaviorally anchored probe question is provided for each symptom to increase the reliability of administration. The CAPS has excellent sensitivity (.81) and specificity (.95) (Newman, Kaloupek, \& Keane, 1996). For the purpo
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy - Pain
- BEHAVIORAL Cognitive Behavioral Therapy-Integrated
- BEHAVIORAL Cognitive Processing Therapy - PTSD
- BEHAVIORAL Treat as Usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2004-09 |
| Est. Completion | 2010-09 |
| Phase | NA |
What the finished NCT00127413 record still lists
NCT00127413 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which Cognitive Behavioral Therapy - Pain is the first listed.
NCT00127413 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00127413 about?
NCT00127413 is a clinical study titled "Integrated Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)". The purpose of this study is to examine the efficacy of an integrated treatment for Veterans with comorbid chronic pain and posttraumatic stress disorder (PTSD). It is hypothesized that Veterans who receive the integrated treatment will report more positive outcomes than individuals who are assigned...
What is the current status of trial NCT00127413?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2004-09. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00127413?
The interventions under investigation include: Cognitive Behavioral Therapy - Pain (BEHAVIORAL), Cognitive Behavioral Therapy-Integrated (BEHAVIORAL), Cognitive Processing Therapy - PTSD (BEHAVIORAL), Treat as Usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT00127413?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00127413's enrollment target sits among peer trials
42 1436th of 2000 higher than 555 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia